TMS Therapy for OCD treatment 

What is repetitive transcranial magnetic Stimulation (rTMS) as an adjunct therapy for OCD?

MagVenture TMS Therapy is FDA cleared as an adjunct therapy for Obsessive Compulsive Disorder (OCD) which uses short magnetic pulses to target the exact areas in the brain that are affected by OCD. Clinical studies have demonstrated that repetitive magnetic stimulation over this part of the brain, the prefrontal cortex, is safe and effective for the adjunct treatment of OCD. Our treatment protocol is 18 minutes daily for 5 days for 6 weeks.

Indications for use:

“As an adjunct for the treatment of adults suffering from obsessive compulsive disorder (OCD).”

TMS Therapy is CE approved as an: “adjunct treatment of adult patients suffering from OCD.” 

Why rTMS – Excellent response and remission

rTMS is an effective and non-invasive alternative for the large number of patients not responding to medication or who cannot tolerate the side effects of medication. rTMS does not require anesthesia- and is not to be confused with ECT (electro convulsive therapy). Clinical trials and experience from clinics offering this treatment show excellent results in terms of response and remission rate. The TMS Therapy delivers non-invasive magnetic pulses to stimulate nerve cells in the part of the brain controlling the mood. The rapid change in the magnetic field induces a current, and if the current induced is of sufficient amplitude and duration, it will activate neurons.

Research shows the rTMS leads to increase in blood flow, increase in glucose metabolism and increases the level of neurotransmitters (dopamine and glutamate) in stimulated regions of the brain. It is known that people suffering from depression have a reduced blood flow, glucose metabolism and generalized activity in the part of the brain that contributes to mood. Repeated stimulation of this area can have an anti-depressant effect on people suffering from major depression. A large meta-analysis comparing rTMS to sham treatment showed a mean effect size of rTMS in depression which is high compared to mean effect sizes for the pharmacotherapy between 17-46%. A double-blind, placebo-controlled trial finds that 61% of patients respond to rTMS therapy with a significant reduction in HAM-D score over the 4-6 treatment time.Often patients suffering from major depression obtain no relief, or inadequate relief, from antidepressants. In many cases, drug therapies induce side effects that result in non-compliance.

rTMS System

The complete TMS Therapy® system with TMS device (the stimulator), treatment chair, coils, isolation transformer, vacuum pump and pillow.

Contact Us to Schedule an Appointment 

call us at 508.418.6888


TMS therapy as an adjunct therapy for OCD based on rTMS is an effective and easy-to-use alternative:

  • Series of pulsed magnetic stimuli to the brain
  • Non-invasive procedure- no anesthetic
  • Outpatient treatment
  • Excellent tolerability
  • Free from anti-depressant side effects
  • Can be used in combination with anti-depressants
  • Does not affect cognitive function
  • Patient can resume normal activities after treatment